PharmiWeb.com - Global Pharma News & Resources
PharmiWeb Today Story
Dr. Stuart Bond Honoured with President’s Award at 19th World Congress of the International Photodynamic Association

The International Photodynamic Association (IPA) is pleased to announce that Dr. Stuart Bond, Consultant Antimicrobial Pharmacist and Director of Innovation at Mid Yorkshire Hospitals NHS Trust, has been awarded the prestigious President’s Award at the 19th World Congress of the IPA, held this year in Shanghai, China.

The President’s Award is one of the IPA’s highest honours, reserved for individuals whose work is making a transformational impact on healthcare through photodynamic therapy. Dr. Bond received this distinguished honour in recognition of his leadership in advancing the use of antimicrobial photodynamic therapy (aPDT, also known as photodisinfection) for infection prevention within the UK's National Health Service (NHS). His pioneering work led to the first implementation of this innovative technology within the NHS for reducing surgical site infections in joint replacement procedures. The Mid Yorkshire team’s results—including a 71% reduction in surgical site infections for knee and hip replacements—highlight both improved patient outcomes and significant cost savings.

“Dr. Bond and his team at Mid Yorkshire were the first to operationalize antimicrobial photodynamic therapy within the NHS,” said Dr. Colin Hopper, President of the IPA. “Their published findings have not only demonstrated the clinical value of aPDT but have also set a benchmark in infection prevention. Their leadership showcases the importance of photodisinfection in an era of rising multidrug resistance and reinforces the NHS as a global leader in antibiotic stewardship and patient safety.”

Dr.…

Read More...
Dr. Stuart Bond Honoured with President’s Award at 19th World Congress of the International Photodynamic Association

Articles